Cyvex Earns Patent for Cognitive Health Fisetin Ingredient
Published on:
Cyvex Nutrition has been issued a Notice of Allowance from the U.S. Patent and Trademark Office for a patent relating to its use of Cognisetin, a fisetin-based ingredient believed to enhance long-term memory.
Cyvex Nutrition (Irvine, CA) has been issued a Notice of Allowance from the U.S. Patent and Trademark Office for a patent relating to its use of Cognisetin, a fisetin-based ingredient believed to enhance long-term memory.
The patent relates to the ingredient’s use of flavonoids to enhance memory.
“The patent describes fisetin as a neuroprotector capable of generating neuron cells in the presence of damage, promoting antioxidant synthesis, and reducing overactive brain-and spinal cord-specific immune defenses that contribute to age-related decline and/or conditions,” said the company in a recent statement.
Matt Phillips, president and CEO of Cyvex Nutrition says that the patent “…validates Cognisetin’s status as a genuinely novel ingredient with a clinically-backed cognitive health benefit.”
